NASHUA, N.H., May 22 /PRNewswire-FirstCall/ -- iCAD, Inc. (NASDAQ:iCAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that the Company's CEO, Ken Ferry, has been invited to participate in the prestigious Future in Review (FiRe) Conference. The Conference runs from May 22 to 25, 2007, at the Hotel del Coronado in San Diego, California. iCAD joins EMC, Symantec and Intel Health Research & Innovation Group, among other technology leaders at the conference. Mark Anderson, founder and publisher of the Strategic News Service and expert source on future technologies, contributes to Fortune, the Wall Street Journal and the New York Times correctly predicting accurate forecasts of important technology market shifts. The FiRe conference hosted by Mark Anderson provides world experts and participants with a view of the future in technology, including nanotechnology, space travel, biology and medical diagnostics, policy, and other fields. "The annual FiRe conference offers participants exposure to new ideas and thought leaders on the cutting edge of technology," said Mark Anderson, chairman of FiRe and founder and publisher of the Strategic News Service. "iCAD was selected to participate in FiRe because the Company's CAD technology is shaping the future of cancer screening, from mammography to virtual colonoscopy and beyond. CAD technology is vital to the early identification of cancer, which studies have shown impacts treatment options, survival and overall patient outcomes." "iCAD is honored to be selected as a participant at the 2007 FiRe conference," said Ken Ferry, Chief Executive Officer of iCAD. "As the only company 100 percent focused on advancing CAD solutions, iCAD is leading the development of future systems that enable physicians to detect cancers earlier. The Company's commitment to digital imaging will continue to expand as we explore applications in 3D mammography and virtual colonoscopy." About iCAD, Inc. iCAD, Inc. (NASDAQ:iCAD) is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1-877-iCADnow or visit http://www.icadmed.com/. For iCAD Investor Relations, contact Kevin McGrath of Cameron Associates at 212-245-4577 or via email at For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via e-mail at DATASOURCE: iCAD, Inc. CONTACT: For iCAD Investor Relations: Kevin McGrath of Cameron Associates, +1-212-245-4577, , or for iCAD Public Relations: Wendy Ryan of Schwartz Communications, +1-781-684-0770, Web site: http://www.icadmed.com/

Copyright